Drug Search Results
More Filters [+]

Cordycepin

Alternative Names: cordycepin
Latest Update: 2024-05-13
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: ADORA3 Stimulant

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: OncoVista
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Cordycepin

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Leukemia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ChiCTR2400088428

N/A

Not yet recruiting

Asthenia

2027-02-28

ChiCTR2300075042

N/A

Recruiting

Non-Small-Cell Lung Cancer|Small Cell Lung Cancer

2025-06-01

ChiCTR-INR-17014074

N/A

Not yet recruiting

Depressive Disorder, Major

2019-12-31

OV06-001

P2

Unknown status

Leukemia

2010-12-01

Recent News Events